Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MCEE | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | TMEM267 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | MED31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | U2AF1L4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | SRCAP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | SLC39A5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | N4BP2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | OR52E5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | PHB | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |